Metformin Pinewood Laboratories

Metformin, the active ingredient in Metformin Pinewood Laboratories, is a biguanide presented as a unknown/unknown for oral use. It treats type 2 diabetes mellitus in adults.

GNH USA supplies Metformin Pinewood Laboratories as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is an oral antidiabetic that acts on glucose metabolism. - Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial glucose levels. - Prediabetes (impaired glucose tolerance): helps delay progression to type 2 diabetes. - Polycystic ovary syndrome: reduces insulin resistance and may improve menstrual regularity.

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, and loss of appetite. - Diarrhea: frequent loose stools, especially during treatment initiation. - Metallic taste: transient alteration in taste perception. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening accumulation of lactate. - Severe hypoglycemia: may occur when combined with insulin or secretagogues. - Vitamin B12 deficiency: long‑term therapy can reduce B12 absorption. - Hepatic dysfunction: rare liver enzyme elevations. - Skin rash or hypersensitivity reactions. - Acute pancreatitis: infrequent but serious pancreatic inflammation.

Metformin requires careful patient assessment and monitoring. - Renal function: evaluate eGFR before starting and periodically thereafter. - Hepatic impairment: use with caution; monitor liver enzymes. - Cardiovascular disease: assess risk of lactic acidosis in unstable patients. - Alcohol consumption: limit intake to reduce lactic acidosis risk. - Pregnancy and lactation: weigh benefits against potential risks; consult obstetric guidance. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Metformin may interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of lactic acidosis; discontinue before imaging. - Cimetidine: can raise metformin plasma concentrations. - Alcohol: potentiates lactic acidosis risk.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Thiazide diuretics: can attenuate glucose‑lowering effect. - ACE inhibitors or ARBs: monitor renal function and potassium levels.